Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 20,6x - 22,7x | 21,7x |
| Selected Fwd EBIT Multiple | 20,5x - 22,7x | 21,6x |
| Fair Value | ₩6.500 - ₩7.452 | ₩6.976 |
| Upside | 13,8% - 30,5% | 22,2% |
| Benchmarks | Ticker | Full Ticker |
| BCWORLD PHARM. Co., Ltd. | A200780 | KOSDAQ:A200780 |
| DAE HWA Pharmaceutical Co., Ltd. | A067080 | KOSDAQ:A067080 |
| Kukje Pharma Co., Ltd. | A002720 | KOSE:A002720 |
| Sam-A Pharm. Co., Ltd | A009300 | KOSDAQ:A009300 |
| Ahn-Gook Pharmaceutical Co., Ltd. | A001540 | KOSDAQ:A001540 |
| Sinsin Pharmaceutical Co., Ltd | A002800 | KOSDAQ:A002800 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A200780 | A067080 | A002720 | A009300 | A001540 | A002800 | ||
| KOSDAQ:A200780 | KOSDAQ:A067080 | KOSE:A002720 | KOSDAQ:A009300 | KOSDAQ:A001540 | KOSDAQ:A002800 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | 3.2% | 3.8% | 18.7% | 22.5% | 24.2% | |
| 3Y CAGR | NM- | 26.9% | NM- | 59.3% | NM- | NM- | |
| Latest Twelve Months | 289.5% | 936.3% | 1488.7% | -46.6% | 136.2% | 7.5% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 0.5% | 3.1% | 1.8% | 18.5% | 1.9% | 2.3% | |
| Prior Fiscal Year | 8.5% | 1.4% | -1.5% | 24.2% | 2.2% | 5.9% | |
| Latest Fiscal Year | 2.0% | 4.5% | 4.3% | 25.6% | 2.5% | 6.5% | |
| Latest Twelve Months | 4.6% | 4.4% | 5.0% | 18.0% | 4.4% | 6.1% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.52x | 2.30x | 0.63x | 0.31x | 0.30x | 1.17x | |
| EV / LTM EBITDA | 10.2x | 26.7x | 9.1x | 1.3x | 4.1x | 11.6x | |
| EV / LTM EBIT | 33.3x | 52.4x | 12.5x | 1.7x | 6.9x | 19.2x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 1.7x | 12.5x | 52.4x | ||||
| Historical EV / LTM EBIT | -85.0x | 19.1x | 23.7x | ||||
| Selected EV / LTM EBIT | 20.6x | 21.7x | 22.7x | ||||
| (x) LTM EBIT | 6,516 | 6,516 | 6,516 | ||||
| (=) Implied Enterprise Value | 134,089 | 141,147 | 148,204 | ||||
| (-) Non-shareholder Claims * | (38,500) | (38,500) | (38,500) | ||||
| (=) Equity Value | 95,590 | 102,647 | 109,704 | ||||
| (/) Shares Outstanding | 15.2 | 15.2 | 15.2 | ||||
| Implied Value Range | 6,301.02 | 6,766.22 | 7,231.42 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 6,301.02 | 6,766.22 | 7,231.42 | 5,710.00 | |||
| Upside / (Downside) | 10.4% | 18.5% | 26.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A200780 | A067080 | A002720 | A009300 | A001540 | A002800 | |
| Enterprise Value | 114,876 | 346,783 | 106,016 | (35,776) | 88,366 | 125,123 | |
| (+) Cash & Short Term Investments | 5,631 | 6,780 | 12,537 | 88,314 | 48,832 | 748 | |
| (+) Investments & Other | 3,078 | 3,823 | 4,605 | 62,102 | 27,238 | 7,772 | |
| (-) Debt | (86,406) | (98,217) | (29,477) | (9,906) | (77,861) | (47,295) | |
| (-) Other Liabilities | (50) | (4,651) | (15) | 0 | 1,052 | 275 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 37,130 | 254,517 | 93,668 | 104,733 | 87,627 | 86,624 | |
| (/) Shares Outstanding | 8.4 | 17.5 | 20.4 | 6.1 | 11.4 | 15.2 | |
| Implied Stock Price | 4,400.00 | 14,530.00 | 4,600.00 | 17,160.00 | 7,710.00 | 5,710.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4,400.00 | 14,530.00 | 4,600.00 | 17,160.00 | 7,710.00 | 5,710.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |